All lobbying filings

ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Trade association

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 16, 2026

Official filing document

Bills named in this filing 3

S 2296
National Defense Authorization Act for Fiscal Year 2026
HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025

Lobbying activity 3

Defense

BIOSECURE Act/S. Amdt. 3236 to S. 2296, the National Defense Authorization Act for FY2026.

Medicare/Medicaid

Issues related to reimbursement under Medicare Part B and Part D; Most Favored Nation (MFN).

Health Issues

Issues related to drug pricing, generally; 340B Drug Pricing Program; pharmacy benefit managers; drug patents and patent reporting requirements; H.R. 1262/S. 932, Give Kids a Chance Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.